Skip to Content

Basic Research Papers

  1. Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF. Insulin-like Growth Factor-2 (IGF2) Loss of Imprinting Marks a Field Defect Within Human Prostates Containing Cancer. Prostate. 2011 Nov;71(15):1621-30. PubMed PMID: 21432864.

  2. Truong M, Yang B, Wagner J, Kobayashi Y, Rajamanickam V, Brooks J, Jarrard DF. Even-skipped Homeobox 1 is Frequently Hypermethylated in Prostate Cancer and Predicts PSA Recurrence. Br J Cancer. 2012 Jun 26; 107(1):100-7. PubMed PMID: 22596233; PubMed Central PMCID: PMC3389415.

  3. Ewald JA, Jarrard DF. Decreased skp2 Expression is Necessary but Not Sufficient for Therapy-induced Senescence in Prostate Cancer. Transl Oncol. 2012 Aug;5(4):278-87. PubMed PMID: 22937180; PubMed Central PMCID: PMC3431038.

  4. Truong M, Yang B, Wagner J, Desotelle J, Jarrard DF. Analysis of Promoter Non-CG Methylation in Prostate Cancer. Epigenomics. 2013 Feb;5(1):65-71. PubMed PMID: 23414321.

  5. Ewald JA, Desotelle JA, Church DR, Yang B, Huang W, Laurila TA, Jarrard DF. Androgen Deprivation Induces Senescence Characteristics in Prostate Cancer Cells in Vitro and in Vivo. Prostate. 2013 Mar;73(4):337-45. PubMed PMID: 22911222.

  6. Slezak J, Truong M, Huang W, Jarrard D. HP1γ Expression is Elevated in Prostate Cancer and is Superior to Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy. BMC Cancer. 2013 Mar 23;13:148. PubMed PMID: 23522301.

  7. Yang B, Bhusari S, Kueck J, Weeratunga P, Wagner J, Leverson G, Huang W, Jarrard DF. Methylation Profiling Defines an Extensive Field Defect in Histologically Normal Prostate Tissues Associated with Prostate Cancer. Neoplasia. 2013 Apr;15(4):399-408. PubMed PMID: 23555185.

  8. Truong M, Yang B, Livermore A, Wagner J, Weeratunga P, Huang W, Dhir R, Nelson J, Lin DW, Jarrard DF. Using the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy-Negative Patients. J Urol. 2012 Nov 15. PubMed PMID: 23159584. PMCID: PMC4226217.

  9. Damaschke NA, Yang B, Bhusari S, Svaren JP, Jarrard DF. Epigenetic Susceptibility Factors for Prostate Cancer with Aging. Prostate. 2013 Sep 2. PubMed PMID: 23999928.

  10. Yang B, Wagner J, Damaschke N, Yao T, Wuerzberger-Davis SM, Lee MH, Svaren J, Miyamoto S, Jarrard DF. A Novel Pathway Links Oxidative Stress to Loss of Insulin Growth Factor-2 (IGF2) Imprinting Through NF-κB Activation. PLoS One. 2014 Feb 18;9(2): PubMed PMID: 24558376; PubMed Central PMCID: PMC3928145.

  11. Yu YP, Ding Y, Chen Z, Liu S, Michalopoulos A, Chen R, Gulzar ZG, Yang B, Cieply KM, Luvison A, Ren BG, Brooks JD, Jarrard DF, Nelson JB, Michalopoulos GK, Tseng GC, Luo JH. Novel Fusion Transcripts Associate with Progressive Prostate Cancer. Am J Pathol. 2014 Oct;184(10):2840-9. PubMed PMID: 25238935; PubMed Central PMCID: PMC4188871.

  12. Damaschke NA, Yang B, Blute ML Jr, Lin CP, Huang W, Jarrard DF. Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer. Neoplasia. 2014 Dec;16(12):1018-27 PubMed PMID: 25499215.

  13. Wagner J, Damaschke N, Truong M, Yang B, Guenther C, Huang W, Jarrard DF. Overexpression of the Novel Senescence Marker β-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence. PLoS One. 2015 Apr 15;10(4):e0124366

  14. Yang B, Damaschke N, Yao T, McCormick J, Wagner J, Jarrard DF. Pyrosequencing for the Accurate Quantification of Imprinting Expression. J Cell Biochem. 2015 Jul;116(7):1165-70

  15. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong, YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Increased Survival with Chemohormonal Therapy in Metastatic Hormone Sensitive Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group. (E3805) N Engl J Med. 2015 Aug 20;373(8):737-46. Copyright © 2018 The Board of Regents of the University of Wisconsin System